These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 25540904)
1. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles. Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904 [TBL] [Abstract][Full Text] [Related]
2. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach. Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration. Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360 [TBL] [Abstract][Full Text] [Related]
4. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597 [TBL] [Abstract][Full Text] [Related]
5. Poly(lactide- Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616 [TBL] [Abstract][Full Text] [Related]
7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
8. Polymeric nanoparticles for siRNA delivery and gene silencing. Patil Y; Panyam J Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242 [TBL] [Abstract][Full Text] [Related]
9. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach. Leng D; Thanki K; Fattal E; Foged C; Yang M Int J Pharm; 2018 Sep; 548(2):740-746. PubMed ID: 28847667 [TBL] [Abstract][Full Text] [Related]
10. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model. Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438 [TBL] [Abstract][Full Text] [Related]
12. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles. Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573 [TBL] [Abstract][Full Text] [Related]
13. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968 [TBL] [Abstract][Full Text] [Related]
14. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577 [TBL] [Abstract][Full Text] [Related]
15. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589 [TBL] [Abstract][Full Text] [Related]
16. Self-assembled siRNA-PLGA conjugate micelles for gene silencing. Lee SH; Mok H; Lee Y; Park TG J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893 [TBL] [Abstract][Full Text] [Related]
17. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach. Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906 [TBL] [Abstract][Full Text] [Related]
18. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633 [TBL] [Abstract][Full Text] [Related]